Immutep
IMMP
#7821
Rank
ยฃ0.24 B
Marketcap
ยฃ1.69
Share price
-0.88%
Change (1 day)
-1.18%
Change (1 year)

Revenue for Immutep (IMMP)

Revenue in 2024: N/A

According to Immutep's latest financial reports the company's current revenue (TTM ) is -ยฃ0.01 Million. In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Immutep from 2008 to 2024

Annual revenue

Year Revenue Change
2024N/A
2023N/A-100%
2022ยฃ0.08 M
2021N/A-100%
2020ยฃ3.88 M5163.29%
2019ยฃ0.07 M-94.96%
2018ยฃ1.46 M
2017N/A-100%
2016ยฃ0.09 M
2015N/A
2014N/A
2013N/A
2012N/A
2011N/A-100%
2010ยฃ0.03 M75.14%
2009ยฃ0.01 M
2008N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Illumina
ILMN
ยฃ3.22 B-1,548,014,540.43%๐Ÿ‡บ๐Ÿ‡ธ USA
HTG Molecular Diagnostics
HTGM
ยฃ4.66 M-2,243,520.94%๐Ÿ‡บ๐Ÿ‡ธ USA
FibroGen
FGEN
-ยฃ88.7 Million 42,632,751.99%๐Ÿ‡บ๐Ÿ‡ธ USA